Scilex Inks Distribution Agreement For Neuropathic Painkiller ZTlido In The Middle East And North Africa

Author: Akanksha Bakshi | April 17, 2023 10:44am

• Scilex Holding Company (NASDAQ:SCLX), a majority-owned subsidiary of Sorrento Therapeutics, Inc (OTC:SRNEQ), has entered a master distributor agreement with AD Ports Logistics (ADPL).
• ADPL is a subsidiary of the Logistics Cluster, AD Ports Group, a global facilitator of trade, logistics and industry based in Abu Dhabi.
• The master distributor agreement covers the distribution of ZTlido in the UAE, Qatar, Bahrain, Kuwait, Oman, and Egypt.
• ZTlido is a lidocaine topical system approved for relieving neuropathic pain associated with post-herpetic neuralgia (PHN).
• CH Trading Group LLC will continue the process to expand the commercialization of ZTlido in the Middle East and North Africa markets.
• Price Action: SCLX shares are trading higher by 5.87% at $14.25 on the last check Monday.

Posted In: SCLX SRNEQ